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MACE was reported at 30 days.
Results: 685 patients underwent RA PCI (Radial n ¼ 398 and Femoral n ¼ 287)
during the study period. There was a predominance of male patients in the radial group
(75.4% Vs 63.4% p<0.001) and more likely to have left ventricular impairment
(32.8% Vs 15.4%, p<0.001). No other difference in baseline demographics was seen
between the two groups. Procedural success was identical in both cohorts (98.5 Vs
97.5, p¼0.62) but radial cohort received more drug-eluting stents (91.2% Vs 85.3%,
p¼0.03). Guide catheter size in the radial cohort was smaller (6.55F Vs 6.95F,
p<0.001), average burr size was similar. The femoral group underwent more left
main-stem PCI (14.2% Vs 21.8%, p¼0.01) and additional imaging (23.2% Vs 32.9%,
p¼0.03). The procedural time (76.3 vs 92.6mins, p<0.001) and time to ﬁrst balloon
inﬂation (39 vs 54mins, p<0.001) were signiﬁcantly lower in the radial cohort, as was
mean length of stay (1.43 vs 2.93 days, p¼0.008). Bleeding and vascular access
complications were similar between the two groups as was 30 day MACE (Radial
6.45% vs Femoral 4.08%, p¼0.15).
Conclusions: This is the largest comparison to date of radial versus femoral access
rotablation. Our data demonstrate that radial RA PCI can be performed safely, with
smaller guide catheters and similar procedural success. Procedural time and time to
ﬁrst balloon inﬂation was signiﬁcantly less in the radial cohort, whereas 30-day
MACE rates and access-associated complications were similar between both groups.
Our results show that radial access is safe, effective and perhaps more efﬁcient method
for performing RA.
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Assessment the performance value of CRUSADE and MEHRAN bleeding risk
scores with the observed bleeding events among ACS Tunisian patients.
Faouzi Addad1, Zhor Rezine1, Zied Ibn El Hadj1, Nadia Hammami1,
Lobna laaroussi1, Majdi Ammami1, Chaker Oueslati1, Salem Kachboura1
1university hospital of Abderhammen Mami, Ariana, Tunisia
Background: Bleeding is a major complication in patients treated for acute coronary
syndromes (ACS) with antithrombotic and invasive strategy. Consequently, the
beneﬁt of such therapies should be balanced against the potential risk of hemorrhagic
complications. CRUSADE and more recently MEHRAN models provide two risk
scores that predict the likelihood of major bleeding in patients hospitalized with ACS.
The aim of this study: was to evaluate the performance of both CRUSADE AND
MEHRAN risk scores to predict in-hospital major bleeding in a contemporary cohort
of patients hospitalized for ACS in One center in Tunisia.
Methods: The study subjects were 278 consecutive patients admitted to our center
between January 2010 and August 2011 with ACS. For each patient, we calculated
both the CRUSADE and MEHRAN risk score and evaluated its discrimination by the
C statistic.
Results: By CRUSADE and MEHRAN risk scores, our patients were classiﬁed as
high or very high risk of major bleeding in 24.8%, 45.7% of cases, respectively. The
overall incidence of in-hospital bleeding events and major bleeding (BARC major
deﬁnition: BARC 3, BARC 4 and BARC 5) was 12.6%, 4.4%, respectively. The
major bleeding rate increased with the CRUSADE risk category: very low 2.3%; low
3%; moderate 3.6%; high 8.1%; and very high 9.4%.There were twice fewer observed
major hemorrhagic events than predict in case of high and very high risk according to
CRUSADE score. A stepwise increase in rates of major bleeding with increasing
MEHRAN score was also noted (low 0%, moderate 4.9%, high 4.4% vs very high
10.2%). The incidence of the major bleeding predicted by MEHRAN is rather close to
that observed in our population. The curve ROC showed a better correlation of the
MEHRAN score (area under the curve 0.76) than the Crusade score (area under the
curve 0.67) with the major bleeding events observed.
Conclusions: Conclusions: In our clinical practice, bleeding is a relatively frequent
non-cardiac complication of contemporary therapy for ACS especially in high risk
patients. The MEHRAN score seems more correlated to the real life of the Tunisian
coronary patients.
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A new prognostic risk score including platelet reactivity for bleeding after
percutaneous coronary intervention via the femoral approach
Fabio Mangiacapra1, Emanuele Barbato2, Elisabetta Ricottini1, Giuseppe Patti1,
Vincenzo Vizzi1, Andrea D'Ambrosio1, Bernard De Bruyne2
1Campus Bio-Medico University of Rome, Rome, Italy, 2Cardiovascular Center Aalst,
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Background: Platelet reactivity (PR) may predict bleeding events after percutaneous
coronary intervention (PCI), which are associated with increased risk of death. Based
on a bleeding risk score (BRS) of clinical and procedural variables (bleedingriskscore.
org), we developed and validated a new prognostic risk score also including PR
(BRS-PR).
Methods: A total of 800 patients receiving clopidogrel and undergoing elective
PCI via the femoral approach were included in this study. PR was measured
immediately before PCI with the VerifyNow P2Y12 Assay. Calculation of the BRS
included the following variables: age, gender, intra aortic balloon pump, glycoprotein
IIb/IIIa inhibitors, chronic kidney disease, anemia, low-molecular-weight heparinB96 JACC Vol 62/18/Suppl B j October 27–Novwithin 48h pre-PCI. Low-platelet reactivity (LPR), deﬁned as a PR value 178
P2Y12 reaction units, was also included in BRS-PR and assigned a weighted
integer based on multivariable model of predictors of Thrombolysis in Myocardial
Infarction (TIMI) bleedings. Bleeding events were monitored up to 30 days
after PCI and deﬁned according to the TIMI, Randomized Evaluation in PCI
Linking Angiomax to Reduced Clinical Events (REPLACE-2) and Bleeding
Academic Research Consortium (BARC) deﬁnitions. BRS-PR was also tested in the
ARMYDA-BLEEDS study population (n¼310) for TIMI bleedings for validation
purpose.
Results: A total of 28 (3.5%) TIMI, 44 (5.5%) BARC class 2 and 32 (4%)
REPLACE-2 bleedings occurred. In the development set, BRS-PR could signiﬁcantly
discriminate between patients with and without bleeding (AUC >0.8 for all bleeding
deﬁnitions). Discriminatory power of BRS-PR was signiﬁcantly better than that of
BRS alone (p<0.001 for all bleeding deﬁnitions). In the validation set, BRS-PR could
signiﬁcantly discriminate between patients with and without TIMI bleeding with an
AUC of 0.788, with a better discriminatory power compared with that of BRS alone
(AUC¼0.709, p¼0.036).
Conclusions: Including PR in a risk score of clinical and procedural variables
improves prediction of bleeding events after PCI via the femoral approach.
TCT-298
Radial versus Femoral Accesses for Percutaneous Coronary Interventions in
Patients with Acute Coronary Syndromes
Elmir Omerovic1, Elmir Omerovic1
1Sahlgrenska University Hospital, Gothenburg, Sweden
Background: The purpose of this observational study was to evaluate the prognostic
effects of radial artery access (RA) versus femoral artery access (FA) in patients
undergoing percutaneous coronary intervention (PCI) due to acute coronary syndrome
i.e. ST-elevation myocardial infarction (STEMI) and unstable angina/non-STEMI
(UA/NSTEMI).
Methods: Data were obtained from the SCAAR registry (Swedish Coronary Angi-
ography and Angioplasty Registry) for PCI procedures performed in Västra Götaland
region in Sweden between 2005-2011. We evaluated 30-days mortality in 10007
patients, N¼4386 in RA and N¼5621 in FA. The two groups were compared using
Cox proportional hazards regression with "shared frailty" to account for hierarchical
database. Adjustments for differences in baseline characteristics were made with
propensity score. The following variables were included in the calculation of the
propensity score: age, gender, indication for PCI, smoking habits, hypertension,
diabetes, hyperlipidaemia, severity of coronary artery disease, previous infarction,
previous PCI, previous coronary artery by-pass surgery (CABG), anticoagulation
therapy with glycoprotein IIb/IIIa receptor antagonists (GP IIb/IIIa), bivalirudin,
clopidogrel, unfractionated heparin/low-molecular weight heparins (UH/LMWH),
year, hospital.
Results: The two groups were balanced regarding age, gender, diabetes, smoking
habits, hypertension and hyperlipidaemia. RA patients were more likely to be pre-
treated with aspirin, clopidogrel and to receive bivalirudin and drug-eluting stents
during the procedure. FA patients were more likely to had previous myocardial
infarction, previous PCI, previous CABG and to receive GP IIb/IIIa and UH/LMWH
during the procedure. There were 3761 patients (37.6%) with STEMI and 6246
(62.4%) with UA/NSTEMI. More patients with STEMI underwent PCI through FA.
RA was associated with 38% reduction in 30-days mortality (1.5% vs. 2.8%; HR 0.62;
95% CI 0.44–0.87; p ¼ 0.005).
Conclusions: In patients with acute coronary syndromes, PCI through radial artery
access is associated with reduced 30-days mortality. A properly designed randomised
clinical trial is urgently needed to test the hypothesis that radial artery access decreases
mortality in patients with acute coronary syndrome.
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Comparison of Slender (6.5 French Sheathless) Guiding Catheters Versus 5
French Guiding Catheters for Slender Transradial Coronary Intervention.
Chin Yong Ang1, Huynh Linh Dinh1, Anthony N. Lontoc1, Bing Liu2, Victor Lim3,
Soo Teik Lim1, Tian Hai Koh1, Paul T. Chiam1
1National Heart Centre Singapore, Singapore, Singapore, 2Beijing Hospital, Beijing,
China, 3National Heart Centre Singapore, Singapore, SIngapore
Background: Transradial coronary intervention (TRI) is increasingly performed, with
the standard 6 French (Fr) guiding catheters (GC) employed by most operators.
However, based on the radial artery size, only up to 72% of female and 85% of male
Asian patients can physically accept the 6 Fr sheath. The 5 Fr GC reduces patient
discomfort, radial artery spasm and occlusion (RAO), although there is a need to
crossover to the 6 Fr GCs in a small proportion of cases. The novel sheathless (SH)
GCs maintains the advantage of the The aim of this study is to assess the safety and
efﬁcacy of a sheathless (SH) 6.5 Fr hydrophilic-coated guiding catheter (outer
diameter nearly equivalent to a 4F sheath – "virtual 4F guiding catheter") compared to
the standard 5 Fr GCs in TRI.
Methods: Patients undergoing TRI between November 2008 and June 2013 were
included. Baseline characteristics and in-hospital outcomes were recorded. Primary
endpoints were procedural success and presence of radial pulse at discharge.ember 1, 2013 j TCT Abstracts/POSTER/Vascular Access and Closure
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site complications, procedural duration and amount of contrast used.
Results: There were 832 procedures included with 145 cases using 5Fr GC system
and 686 cases using SH GC system. No signiﬁcant difference noted between the 2
groups in terms of target vessel, lesion morphology (ACC/AHA lesion classiﬁcation),
and mean procedure time. Procedural success was 95.2% and 96.6% respectively
(p¼0.396). One patient in each group (0.7% vs 0.1%) experienced RAO without
signiﬁcant clinical sequelae . Contrast load (16468 ml vs. 14045 ml, p<0.001)
were greater in the SH group. (See Table 1)Results
5 French
Group
(N=146)
Sheathless
Group
(N=686) P-value
Procedure Success (%) 139(95.2) 663(96.6) 0.396
Failed PCI e.g. inadequate GC
backup, unable to deliver stent
(excluding CTO)
4(2.7) 8(1.2) 0.148
Failed PCI (CTO) 0 8(1.2) 0.190
Stent dislodgement 0 3(0.4) 0.423
GC success engagement (%) 143(97.9) 679 (98.9) 0.298
Procedure Time (min) 45(+/-21) 48(+/-20) 0.078
Contrast used (ml) 140(+/-45) 164(+/-68) <0.001
Lesion treated per procedure (%) 1.65 1.67 0.887
Post-procedural radial artery occlusion
(%)
1(0.7) 1(0.1) 0.227
MACE in-hospital (%) 1(0.7) 3(0.4) 0.695
Puncture site hematoma (%) 1(0.7) 1(0.1) 0.227
PCI: Percutaneous coronary intervention; GC: Guiding catheter; CTO: Chronic total occlusion;
MACE: Major adverse cardiovascular event.
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procedural TRI success with low RAO rates. The SH GC eliminated the disadvantages
of the 5 Fr GC whilst maintaining the advantage of low RAO rates, and may become
the GC of choice in TRI.
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HASBLED Scale Utility after Percutaneous Coronary Interventions
Adriana De la Rosa Riestra1, Roberto Del Castillo Medina1,
Ester Canovas Rodriguez1, Alfonso Freites Esteves1, Javier Alonso Bello1,
Lorenzo Hernando Marrupe1, Pablo Salinas1, Javier Botas Rodriguez1
1HOSPITAL UNIVERSITARIO FUNDACION ALCORCON, Madrid , Spain
Background: A 20-30% of p (patients) with oral anticoagulation indication
requiring percutaneous coronary intervention (PCI). In this subgroup the risk of
bleeding is high (4-16% annually). HASBLED scale is used to predict the risk of
bleeding in patients with atrial ﬁbrillation. However, it has been well studied its
usefulness in predicting major events in patients with indications for triple therapy
after PCI.
Methods: Observational, prospective consecutive 102p (track 100% with a mean 25.8
 10.1 months) after PCI and at discharge TT. 2 groups were obtained according to
the scale HASBLED <3 (low-intermediate risk 55p, 53.9%) or HASBLED  3 (high
risk 47p, 46.1%). Survival was assessed with Kaplan-Meier curves and log-rank test,
multivariate analysis using a Cox-proportional hazards model for bleeding and MACE
(cardiac death, nonfatal MI, revascularization, stroke) at each group.
Results: Group HASBLED3 showed signiﬁcant differences with worse CHA2DS2-
VASC score (4.21.3 vs 3.11.6, p <0.05) and lower baseline hemoglobin level
(12.41.7 vs 13.21.5, p<0.05) compared with HASBLED<3. Overall bleeding rate
(30.9% and 27.7%, ns) and transfusion needing (16.4% vs 6.4%, ns) was similar for
both groups. MACE incidence was unfavorable for HASBLED3 group (34.5% vs
14.9%, p ¼ 0.02) due to the rate of stroke (12.2% vs 2.2%, p¼0.03) and cardiac death
(10.9% vs 0.0%, p 0.02). Overall mortality was also signiﬁcantly higher in the group
HASBLED3 (21.8% vs 6.4%, p<0.05). Mean time to MACE was lower for
HASBLED3 group (41.32.3 vs 46.20.8 months, log-rank test p <0.05). Having
a CHA2DS2-VASC score> 2 was associated with increased risk major cardiovascular
events with a HR¼4.6 95% CI[1.2 to 80.6], p¼0.03. Mean time to bleeding event was
similar in both groups (110884 vs 112892 days, log-rank test p¼0.83). Suffering
renal insufﬁciency (Cr> 1.5 mg / dl) trended to an increased risk of bleeding with
a HR¼6.8 95% CI [0.9 to 50.0], (p¼0.05).
Conclusions: Having a HASBLED score 3 seems to identify the subgroup of
patients with higher risk of mortality and major cardiovascular events among those onJACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstrtriple therapy after PCI, without providing a clear value as a predictor tool for bleeding
in this subset.
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Is there a role for BivaliRUdin in Transradial Percutaneous Coronary
Intervention? - The BRUT PCI Study
Sundeep Adusumalli1, Gregory Harris1, Arjun Chagarlamudi1, Gary M. Nash1,
Adeel Siddiqui1, Nikhil Paladugu1, Ramesh B. Daggubati1
1East Carolina University, Greenville, NC
Background: In this study we sought to compare the clinical outcomes in patients
undergoing percutaneous coronary interventions (PCI) in respect to reducing bleeding
strategies. Recent studies have shown transradial PCI is superior to transfemoral PCI.
Data suggests that the use of bivalirudin is superior to heparin when analyzing overall
outcomes in coronary PCI via transfemoral approach. There is a paucity of data when
comparing different strategies to reduce bleeding.
Methods: 1722 patients at a high volume university medical center undergoing
coronary PCI were retrospectively divided into four groups (femoral artery access
with heparin, femoral with bivalirudin, radial with heparin/LMWH, and radial
with bivalirudin). Cardiology fellows obtained access in greater than 90% of all
patients.
Results: Incremental beneﬁt is noted in all outcomes between the four groups.Conclusions: In this single center study, incremental beneﬁt is noted in bleeding
reducing strategies. Bivalirudin may be beneﬁcial in Transradial PCI. Further studies
to evaluate transradial coronary PCI using bivairudin are warranted.
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Efﬁcacy of Transradial Approach for Coronary Angiography in Octogenarian
Patients with Severe Aortic Stenosis
Ivan Gomez-Blazquez1, José Antonio B. Alonso1, Guillermo Bastos1,
Antonio de Miguel1, Victor A. Jimenez1, Alberto Ortiz1, Andres Iñiguez1
1Hospital Meixoeiro, Complejo Hospitalario Universitario de Vigo, Vigo, Spain
Background: Octogenarians undergoing transcatheter valve implantation or sur-
gical valve replacement for severe aortic stenosis are increasing worldwide. They have
an increased risk for periprocedural complications associated to pre-operative
coronary angiography (CA). Although transradial approach (TRA) constitutes an
alternative to reduce vascular complications, tortuosity of vessels and aortic root
dilation in elderly patients with aortic valve stenosis might lead to TRA failure. Our
aim was to evaluate the efﬁcacy of TRA for CA in octogenarians with severe aortic
stenosis.
Methods: From January 2006 to May 2013, a total of 717 octogenarian patients with
severe aortic stenosis underwent CA by TRA as initial route of access at our center.
Procedural failure was deﬁned as the need to change to another vascular route to
complete the CA.
Results: Mean age of patients was 83.73.0 years and 58.2% were females.
The initial approach was right TRA in 637 (88.8%) patients and left TRA in 80
(11.2%) patients. Tortuosity of subclavian artery was present in 101 patients
(14.1%), tortuosity of radial artery in 116 patients (16.2%) and severe spasm of
radial artery in 35 patients (4.9%). Of total, 49 patients (6.8%) had aortic root
dilation with maximum diameter >50 mm and 53 patients (7.4%) had severe
aortic valve regurgitation. Vascular complication (hematoma >5 cm or radial
artery perforation) occurred in 7 patients (1%). Procedural failure rate was 6.7%
and the crossover to femoral artery was required in 26 cases (3.6%). Logistic
regression analysis demonstrated as predictors of TRA failure: tortuosity of
subclavian artery (OR 4.37 [95% CI 2.28-8.37]), severe spasm of radial artery (OR
3.05 [95% CI 1.21-7.70]) and severe aortic regurgitation (OR 3.27 [95% CI
1.10-10.58]).
Conclusions: In our series of octogenarian patients with severe aortic stenosis, TRA
approach for coronary angiography was associated with low rate of procedural failure,
being tortuosity of subclavian artery, severe spasm of radial artery and severe aortic
regurgitation the main predictors of failure.acts/POSTER/Vascular Access and Closure B97
